Cited by 62Adipokines, Inflammation, and Metabolic DiseasesPeroxisome Proliferator-Activated ReceptorsAdipose Tissue and Metabolism

Regulation of adiponectin and leptin secretion and expression by insulin through a PI3K-PDE3B dependent mechanism in rat primary adipocytes

Open access
Cong, Li, Chen, Ke, Li, Ji, Gao, Ping, Li, Qiang, Mi, Shuhua, Wu, Xin, Zhao, Allan Z.·2007·Biochemical Journal

Abstract

Adiponectin is intimately involved in the regulation of insulin sensitivity, carbohydrate and lipid metabolism, and cardiovascular functions. The circulating concentration of adiponectin is decreased in obesity and Type 2 diabetes. The present study attempts to elucidate the mechanisms underlying the regulation of adiponectin secretion and expression in rat primary adipocytes. The β-agonist, isoprenaline, decreased adiponectin secretion and expression in a dose-dependent manner in primary adipocytes. Importantly, such an inhibitory effect could be blocked by insulin. The opposing effects of isoprenaline and insulin could be explained by differential regulation of intracellular cAMP levels, since cAMP analogues suppressed adiponectin secretion and expression in a fashion similar to isoprenaline, and insulin blocked the inhibitory effects of the cAMP analogue hydrolysable by PDE (phosphodiesterase). A specific PDE3 inhibitor, milrinone, and PI3K (phosphoinositide 3-kinase) inhibitors abolished the effects of insulin on adiponectin secretion and expression. In the same studies, leptin secretion and expression displayed a similar pattern of regulation to adiponectin. We conclude that insulin and β-agonists act directly at the adipocytes in opposing fashions to regulate the production of adiponectin and leptin, and that a PI3K-PDE3B-cAMP pathway mediates the effects of insulin to restore β-agonist/cAMP-suppressed secretion and expression of these two adipokines.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj20061478

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Insulin modulates expression of adiponectin, abundance of its receptor in adipose and muscle tissue, and its secretion.

    “Likewise, insulin modulates the expression of adiponectin, another well-known adipokine, the abundance of its receptor in adipose and muscle tissue265, 266 as well as its secretion.267, 268”

    From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [267]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cong, L., Chen, K., Li, J., Gao, P., Li, Q., Mi, S., Wu, X., & Zhao, A. Z.
Affiliations
  • Department of Cell Biology and Physiology, University of Pittsburgh, S-326, 3500 Terrace Street, Pittsburgh, PA 15261, U.S.A.
  • University of Pittsburgh (US)
Venue
Biochemical Journal
Published
2007-04-12
Volume
403
Issue
3
Pages
519-525
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W1976974669
Cited by
62
References
38
Citations by year
2025: 2 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 5 · 2018: 2 · 2016: 3 · 2015: 3 · 2014: 8 · 2013: 3 · 2012: 2
FWCI
3.21
Type
journal article
Language
en
Open access
Locations
  • Biochemical Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • National Institutes of Health (5r01dk064383-04)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK064383, R01 DK064383-01)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
adiponectin, leptin, insulin, adipocytes, phosphatidylinositol 3-kinase, PDE3B, cAMP signaling, isoproterenol, beta-adrenergic agonists, adipokine secretion, milrinone, type 2 diabetes, obesity
MeSH terms
Wortmannin, Phosphoinositide-3 Kinase Inhibitors, Adrenergic beta-Agonists, Androstadienes, Animals, Chromones, Insulin, Isoproterenol, Male, Morpholines, 3',5'-Cyclic-AMP Phosphodiesterases, 8-Bromo Cyclic Adenosine Monophosphate, Rats, Sprague-Dawley, Adipocytes, Milrinone, Leptin, Rats, Adiponectin, Cyclic Nucleotide Phosphodiesterases, Type 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review